JFLLIFE — JFL Life Sciences Balance Sheet
0.000.00%
- IN₹356.03m
- IN₹564.45m
- IN₹1.31bn
Annual balance sheet for JFL Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | R2023 March 31st | R2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | — | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1.9 | 0.866 | 0.614 | 0.355 | 8.88 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 241 | 246 | 258 | 349 | 533 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 393 | 440 | 436 | 595 | 915 |
| Net Property, Plant And Equipment | 71.3 | 68 | 125 | 122 | 145 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 483 | 515 | 567 | 719 | 1,062 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 284 | 182 | 206 | 316 | 530 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 370 | 193 | 211 | 325 | 604 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 113 | 323 | 356 | 395 | 459 |
| Total Liabilities & Shareholders' Equity | 483 | 515 | 567 | 719 | 1,062 |
| Total Common Shares Outstanding |